Seraxis, Inc. | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Seraxis, Inc.

BRIEF

published on 06/14/2024 at 15:05, 5 months 6 days ago

Seraxis Secures $400,000 Maryland Stem Cell Research Fund Grant for Pancreatic Islet Replacement Therapy

Stem Cell Research Seraxis Pancreatic Islet Replacement Type 1 Diabetes MSCRF Grant
PRESS RELEASE

published on 06/14/2024 at 15:00, 5 months 6 days ago

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
Seraxis, Inc. awarded $400,000 MSCRF grant to advance SR-03 cell line for diabetes treatment. Meeting at ADA Annual Meeting in Orlando

Diabetes Treatment MSCRF Grant Seraxis Inc. SR-03 Cell Line ADA Annual Meeting
PRESS RELEASE

published on 01/04/2024 at 15:00, 10 months 16 days ago

Seraxis' Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes
Seraxis, Inc., a regenerative medicine company, has announced the completion of a GMP-compliant manufacturing audit for its pancreatic islet replacement therapy program. The audit revealed no critical or major observations, positioning the company's SR-02 as one of the industry's leading clinical-stage stem cell-derived pancreatic islet transplant programs. CEO Dr. William Rust will present further data on the development of SR-02 and follow-on immune-cloaked SR-03 at Biotech Showcase in San Francisco.

Seraxis Inc GMP-compliant Manufacturing Pancreatic Islet Transplant Program Stem Cell-derived Therapy Biotech Showcase

Accesswire

Published on 11/21/2024 at 10:03, 43 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 46 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 46 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 11 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 21 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 16 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 41 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 43 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 46 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 46 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 48 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 26 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE